Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is -11.83% vs 8.79% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is -32.46% vs 36.46% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 97.09% vs 44.91% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is -15.94% vs 41.72% in Mar 2023
Compare Profit and Loss Results of Jagsonpal Pharma
Figures in Rs cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
208.00
9,264.00
-9,056.00
-97.75%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
208.00
9,264.00
-9,056.00
-97.75%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-25.00
28.00
112.00%
Raw Materials Consumed
76.00
2,933.00
-2,857.00
-97.41%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
61.00
1,982.00
-1,921.00
-96.92%
Operating Expenses
0.00
143.00
-143.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
19.00
806.00
-787.00
-97.64%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
136.00
-135.00
-99.26%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
185.00
6,939.00
-6,754.00
-97.33%
Operating Profit (PBDIT) excl Other Income
23.00
2,325.00
-2,302.00
-99.01%
Other Income
9.00
266.00
-257.00
-96.62%
Operating Profit (PBDIT)
32.00
2,592.00
-2,560.00
-98.77%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
31.00
2,577.00
-2,546.00
-98.80%
Depreciation
1.00
317.00
-316.00
-99.68%
Profit Before Taxation & Exceptional Items
29.00
2,259.00
-2,230.00
-98.72%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
29.00
2,259.00
-2,230.00
-98.72%
Provision for Tax
7.00
436.00
-429.00
-98.39%
Profit After Tax
22.00
1,823.00
-1,801.00
-98.79%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
94.00
7,868.00
-7,774.00
-98.81%
Profit Available for appropriations
117.00
9,691.00
-9,574.00
-98.79%
Appropriations
117.00
9,691.00
-9,574.00
-98.79%
Equity Dividend (%)
100%
0%
100.00
Earnings Per Share
8.49
45.52
-37.03
-81.35%
Profit And Loss - Net Sales
Net Sales 208.70 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -11.83% vs 8.79% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.07 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -32.46% vs 36.46% in Mar 2023
Profit And Loss - Interest
Interest 0.81 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 97.09% vs 44.91% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 22.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -15.94% vs 41.72% in Mar 2023